2006 Annual Meeting | Headaches in Adults II

Date Sunday 04/02/06

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Todd D. Rozen, MD, FAAN

Topic(s)

Learning Objectives Upon Completion:
Participants should be able to better recognize the trigeminal autonomic cephalagias and develop a treatment scheme for them; be more familiar with headache classification criteria and know how to apply the new International Headache Society criteria when evaluating their patients' headaches; have a better understanding of new daily persistent headache possible pathogenesis and treatment modalities; and be able to better approach the complaint of headache in patients with medical illnesses.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
02:15 PM - 03:00 PM		Headache Classification: Tackling the IHS Criteria Morris Levin, MD, FAAN
03:00 PM - 03:45 PM		Cluster Headache and Other Trigeminal Autonomic Cephalalgias Lawrence C. Newman, MD, FAAN
03:45 PM - 04:00 PM		Break
04:00 PM - 04:45 PM		New Daily Persistent Headache Todd D. Rozen, MD, FAAN
04:45 PM - 05:30 PM		Headache in Patients with Medical Illnesses Thomas N. Ward, MD, FAAN
05:30 PM - 06:00 PM		Discussion

Faculty Disclosures
Morris Levin, MD, FAAN	Dr. Levin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus, Upsher Smith, Biohaven, Revance, Percept, Theranica, Allergan, Alder, Currax. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Attorney . Dr. Levin has received stock or an ownership interest from Percept. Dr. Levin has received publishing royalties from a publication relating to health care.
Thomas N. Ward, MD, FAAN	No disclosure on file
Lawrence C. Newman, MD, FAAN	Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan . Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Newman has received publishing royalties from a publication relating to health care.
Todd D. Rozen, MD, FAAN	No disclosure on file

��ɫ��

��ɫ��